Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Innovative Designs and Analyses for Small Population Clinical Trials

Development Strategies and Operational Engagement for Pediatric and Rare Diseases
BuchGebunden
477 Seiten
Englisch
Springererscheint am20.10.20242024
It provides and illustrates a systematic framework that depends upon a collaborative infrastructure between the patient community, patient advocacy groups, researchers and investigators, pharmaceutical companies, global regulatory agencies, and customers.mehr

Produkt

KlappentextIt provides and illustrates a systematic framework that depends upon a collaborative infrastructure between the patient community, patient advocacy groups, researchers and investigators, pharmaceutical companies, global regulatory agencies, and customers.
Details
ISBN/GTIN978-3-031-60842-1
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2024
Erscheinungsdatum20.10.2024
Auflage2024
ReiheICSA Book Series in Statistics
Seiten477 Seiten
SpracheEnglisch
IllustrationenApprox. 350 p. 40 illus.
Artikel-Nr.55973399

Inhalt/Kritik

Inhaltsverzeichnis
1. Introduction.- 2. The Case Study of NCI-COG Pediatric Match Trials.- 3. The Case Study of Non-oncology (Lonafarnib).- 4. Natural History and Patient Registry.- 5. Diagnostic Criteria and Endpoints.- 6. Enrichment Designs.- 7. Pediatric Extrapolation.- 8. Cross-over Designs.- 9. Adaptive Designs.- 10. Master Protocols.- 11. Other Designs.- 12. Modeling and Simulations.- 13. Frequentist Approaches.- 14. Bayesian Approaches.- 15. Operation and Other Considerations.- 16. Case Studies.mehr

Schlagworte

Autor



Jingjing Ye is Senior Director, Head of Data Science of Operational Excellence (DSOE) in Global Statistics and Data Science (GSDS). She leads a team to promote innovations in various organizations within BeiGene. She has been active in the scientific community, serving as an FDA representative between industry leaders, academic institutions, and the FDA on various scientific working groups, including pediatric, external controls in oncology, simulation in adaptive designs, and quantitative imaging biomarkers. She currently leads several cross-disciplinary working groups, including ASA Biopharmaceutical (BIOP) Section Pediatric Working Group, ASA-DIA Master Protocol and DIA Data Sciences.
Lei Nie is the Associate Division Director for DB II, in the US Food & Drug Administraion. He is an elected fellow of the American Statistical Association and has authored a total of 99 peer-reviewed journal publications. Passionate about multidisciplinary collaboration and the important work performed at the FDA, he always looks for ways to improve efficiencies and to maintain a good work-family balance.
Weitere Artikel von
Ye, Jingjing
Weitere Artikel von
Nie, Lei